---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-021113"
form_type: "8-K"
ticker: "INGN"
cik: "0001294133"
company_name: "Inogen Inc"
filed_at: "2024-02-27T23:59:59+00:00"
generated_at: "2026-06-05T10:55:00.046935+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Inogen Q4 revenue $75.9M (-14% YoY); FY net loss $102.4M, adj EBITDA -$37.8M

## Summary
- Q4 revenue $75.9M vs $88.1M YoY; full-year revenue $315.7M vs $377.2M in 2022.
- Q4 GAAP net loss $26.6M vs $56.6M loss YoY; adjusted net loss $19.4M vs $13.0M loss.
- Full-year GAAP net loss $102.4M vs $83.8M loss; adjusted EBITDA -$37.8M vs -$13.5M.
- Cash, equivalents and marketable securities $128.5M, no debt; gross margin improved to 37.1% in Q4.
- New CCO Grégoire Ramade and CFO Michael Bourque appointed; focus on Physio-Assist U.S. launch.

## SEC filing metadata
- accession: 0000950170-24-021113
- form_type: 8-K
- ticker: INGN
- cik: 0001294133
- company_name: Inogen Inc
- filed_at: 2024-02-27T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1294133/000095017024021113/0000950170-24-021113-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1294133/000095017024021113/ingn-20240227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-021113
- JSON: https://secwatch.observer/filing/0000950170-24-021113.json
- Plain text: https://secwatch.observer/filing/0000950170-24-021113.txt

## Key facts
- Earnings Releases
  Inogen Inc reported the fourth quarter and the full year ended December 31, 2023 results: revenue $75.9 million; full-year 2023 revenue of $315.7 million, net income GAAP net loss for the fourth quarter of 2023 was $26.6 million compared to GAAP net loss of $56.6 million in the fourth.
  - Period: the fourth quarter and the full year ended December 31, 2023
  - Revenue: $75.9 million; full-year 2023 revenue of $315.7 million
  - Net income: GAAP net loss for the fourth quarter of 2023 was $26.6 million compared to GAAP net loss of $56.6 million in the fourth
  - Result: reported results
  source text: Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results Fourth quarter 2023 revenue of $75.9 million; full-year 2023 revenue of $315.7 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1294133/000095017024021113/0000950170-24-021113-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.